The trademark application REVATIS Regenerative medicine and cell therapy was filed by REVATIS S.A., a corporation established under the laws of the Kingdom of Belgium (the "Applicant"). The application was published for oppositions on March 4, 2021, and it was registered by office on June 11, 2021 without any oppositions.
The application was filed in French (English was selected as the second language).
Change of name and address of the trademark registration was recorded on December 17, 2023.
Goods And Services
The mark was filed in class 5 with Pharmaceuticals for use in regenerative medicine.
The mark was filed in class 10 with following description of goods:
Medical apparatus and instruments
Cell culture apparatus for medical or veterinary purposes
Orthopedic articles.
The mark was filed in class 40 with Cellular cryopreservation services.
The mark was filed in class 42 with following description of goods:
Pharmaceutical products development
Development of cell therapy products
Development of technologies for the manufacture and processing of cells to be used as part of advanced cell therapies
Research and development of new products for others.
The mark was filed in class 44 with following description of goods: